Group 1 - Catalyst Pharmaceutical (CPRX) closed at $24.96, with a 0.5% gain over the past four weeks, and a mean price target of $34 indicates a 36.2% upside potential [1] - The average price targets range from a low of $31 to a high of $40, with a standard deviation of $2.98, suggesting a 24.2% to 60.3% upside potential [2] - Analysts show strong agreement on CPRX's ability to report better earnings than previously predicted, which supports the view of potential upside [4][11] Group 2 - The Zacks Consensus Estimate for the current year has increased by 3.5% over the last 30 days, with four estimates moving higher and no negative revisions [12] - CPRX holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - While consensus price targets may not be reliable for predicting exact gains, they can indicate the direction of price movement, which appears to be a good guide [13]
Does Catalyst (CPRX) Have the Potential to Rally 36.22% as Wall Street Analysts Expect?